{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:20:50Z","timestamp":1793647250060,"version":"4.5.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.cbi.2024.111284","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T15:37:50Z","timestamp":1729525070000},"page":"111284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Synthesis and investigation of selective human carbonic anhydrase IX, XII inhibitors using coumarins bearing a sulfonamide or biotin moiety"],"prefix":"10.1016","volume":"404","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5188-2005","authenticated-orcid":false,"given":"Paloma","family":"Begines","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Bonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Giovannuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Nocentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9137-2509","authenticated-orcid":false,"given":"Paola","family":"Gratteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3406-833X","authenticated-orcid":false,"given":"Viviana","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9792-5194","authenticated-orcid":false,"given":"Aday","family":"Gonz\u00e1lez-Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6268-6552","authenticated-orcid":false,"given":"Jos\u00e9 M.","family":"Padr\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemente","family":"Capasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2024.111284_bib1","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3390\/cells10040862","article-title":"Hypoxia and extracellular acidification as drivers of melanoma progression and drug resistance","volume":"10","author":"Dratkiewicz","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.cbi.2024.111284_bib2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/144442b0","article-title":"Carbonic anhydrase","volume":"144","author":"Keilin","year":"1939","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2024.111284_bib3","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3390\/catal10091008","article-title":"Carbonic anhydrases: versatile and useful biocatalysts in chemistry and biochemistry","volume":"10","author":"Angeli","year":"2020","journal-title":"Catalysts"},{"key":"10.1016\/j.cbi.2024.111284_bib4","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3390\/cancers12061616","article-title":"How and why are cancers acidic? Carbonic anhydrase IX and the homeostatic control of tumour extracellular pH","volume":"12","author":"Lee","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.cbi.2024.111284_bib5","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/ijc.34404","article-title":"Chronic acidosis rewires cancer cell metabolism through PPAR\u03b1 signaling","volume":"152","author":"Rolver","year":"2023","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cbi.2024.111284_bib6","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1158\/0008-5472.CAN-03-2224","article-title":"Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion","volume":"64","author":"Robertson","year":"2004","journal-title":"Canc Res"},{"key":"10.1016\/j.cbi.2024.111284_bib7","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/med.21497","article-title":"Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: three for the price of one","volume":"38","author":"Supuran","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.cbi.2024.111284_bib8","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4149\/neo_2018_180819N624","article-title":"High expression of carbonic anhydrase 12 (CA12) is associated with good prognosis in breast cancer","volume":"66","author":"Li","year":"2019","journal-title":"Neoplasma"},{"key":"10.1016\/j.cbi.2024.111284_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112923","article-title":"Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors","volume":"209","author":"Kumar","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2024.111284_bib10","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.3390\/cancers12103018","article-title":"Inhibition of melanoma cell migration and invasion targeting the hypoxic tumor associated CA XII","volume":"12","author":"Giuntini","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.cbi.2024.111284_bib11","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.3390\/cancers14143297","article-title":"Cancer therapeutic targeting of hypoxia induced carbonic anhydrase IX: from bench to bedside","volume":"14","author":"McDonald","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.cbi.2024.111284_bib12","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2024.111284_bib13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1517\/17460441.2015.1038235","article-title":"Designing carbonic anhydrase inhibitors for the treatment of breast cancer","volume":"10","author":"Supuran","year":"2015","journal-title":"Expert Opin Drug Discovery"},{"key":"10.1016\/j.cbi.2024.111284_bib14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/metabo10100412","article-title":"Carbonic anhydrase inhibitors targeting metabolism and tumor microenvironment","volume":"10","author":"Angeli","year":"2020","journal-title":"Metabolites"},{"key":"10.1016\/j.cbi.2024.111284_bib15","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1080\/17460441.2019.1651289","article-title":"Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery","volume":"14","author":"Nocentini","year":"2019","journal-title":"Expert Opin Drug Discovery"},{"key":"10.1016\/j.cbi.2024.111284_bib16","unstructured":"British Columbia Cancer Agency and Welichem Biotech Inc. A study of SLC-0111 and gemcitabine for metastatic pancreatic ductal cancer in subjects positive for CAIX (SLC-0111-17-01). Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03450018."},{"key":"10.1016\/j.cbi.2024.111284_bib17","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1016\/j.bmcl.2011.05.061","article-title":"Synthesis of some new 1,3,5-trisubstituted pyrazolines bearing benzene sulfonamide as anticancer and anti-inflammatory agents","volume":"21","author":"Bashir","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2024.111284_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216338","article-title":"The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugs","volume":"571","author":"Andreucci","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cbi.2024.111284_bib19","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1021\/acsmedchemlett.8b00170","article-title":"Targeting tumor associated carbonic anhydrases IX and XII: highly isozyme selective coumarin and psoralen inhibitors","volume":"9","author":"Melis","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.cbi.2024.111284_bib20","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1080\/14756366.2020.1786821","article-title":"Synthesis, computational studies and assessment of in vitro inhibitory activity of umbelliferon-based compounds against tumour-associated carbonic anhydrase isoforms IX and XII","volume":"35","author":"Mancuso","year":"2020","journal-title":"J Enzyme Inhibition Med Chem"},{"key":"10.1016\/j.cbi.2024.111284_bib21","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2270183","article-title":"2H-chromene and 7H-furo-chromene derivatives selectively inhibit tumour associated human carbonic anhydrase IX and XII isoforms","volume":"38","author":"Sequeira","year":"2023","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.cbi.2024.111284_bib22","doi-asserted-by":"crossref","first-page":"9401","DOI":"10.3390\/ijms24119401","article-title":"Conformationally restricted glycoconjugates derived from arylsulfonamides and coumarins: new families of tumour-associated carbonic anhydrase inhibitors","volume":"24","author":"Mart\u00ednez-Montiel","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2024.111284_bib23","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.2174\/1871520622666220304184525","article-title":"Synthesis and biological evaluation of coumarin carboxamides as selective and potent inhibitors of carbonic anhydrases IX and XII","volume":"22","author":"Thacker","year":"2022","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.cbi.2024.111284_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113875","article-title":"Binding site comparison for coumarin inhibitors and amine\/amino acid activators of human carbonic anhydrases","volume":"226","author":"Petreni","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2024.111284_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2013.04.035","article-title":"Sulfonamides containing coumarin moieties selectively and potently inhibit carbonic anhydrases II and IX: design, synthesis, inhibitory activity and 3D-QSAR analysis","volume":"66","author":"Wang","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2024.111284_bib26","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.bmc.2016.04.052","article-title":"Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XII","volume":"24","author":"Chandak","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2024.111284_bib27","article-title":"Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies","volume":"183","author":"Kurt","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2024.111284_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1515\/hc-2020-0008","article-title":"Coumarin sulfonamide derivatives: an emerging class of therapeutic agents","volume":"26","author":"Irfan","year":"2020","journal-title":"Heterocycl. Commun."},{"key":"10.1016\/j.cbi.2024.111284_bib29","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.3390\/molecules27051604","article-title":"An update on synthesis of coumarin sulfonamides as enzyme inhibitors and anticancer agents","volume":"27","author":"Rubab","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2024.111284_bib30","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/ddr.22049","article-title":"Selective carbonic anhydrase IX and XII inhibitors based around a functionalized coumarin scaffold","volume":"84","author":"Huwaimel","year":"2023","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.cbi.2024.111284_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300316","article-title":"6\u2010Aminocoumarin oxime\u2010ether\/sulfonamides as selective hCA IX and XII inhibitors: synthesis, evaluation, and molecular dynamics studies","author":"Ghouse","year":"2023","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.cbi.2024.111284_bib32","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.jinorgbio.2004.07.009","article-title":"Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumours","volume":"98","author":"Russell-Jones","year":"2004","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.cbi.2024.111284_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf6033","article-title":"A chemical biology approach reveals a dependency of glioblastoma on biotin distribution","volume":"7","author":"Yoon","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.cbi.2024.111284_bib34","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejmech.2018.01.001","article-title":"Biotin conjugated organic molecules and proteins for cancer therapy: a review","volume":"145","author":"Maiti","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2024.111284_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117467","article-title":"Design and synthesis of sulfonamides incorporating a biotin moiety: carbonic anhydrase inhibitory effects, antiproliferative activity and molecular modeling studies","volume":"94","author":"Begines","year":"2023","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2024.111284_bib36","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase I. Stopflow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2024.111284_bib37","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/ddr.21957","article-title":"Click chemistry\u2010based synthesis of new benzenesulfonamide derivatives bearing triazole ring as selective carbonic anhydrase II inhibitors","volume":"83","author":"Ewies","year":"2022","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.cbi.2024.111284_bib38","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.1021\/ja068359w","article-title":"Structural analysis of charge discrimination in the binding of inhibitors to human carbonic anhydrases I and II","volume":"129","author":"Srivastava","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.cbi.2024.111284_bib39","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1107\/S0907444910006554","article-title":"Atomic resolution studies of carbonic anhydrase II","volume":"66","author":"Behnke","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.cbi.2024.111284_bib40","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1021\/acs.jmedchem.5b01343","article-title":"Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX","volume":"58","author":"Leitans","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2024.111284_bib41","doi-asserted-by":"crossref","first-page":"9545","DOI":"10.1073\/pnas.161301298","article-title":"Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells","volume":"98","author":"Whittington","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cbi.2024.111284_bib42","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1080\/14756366.2022.2053526","article-title":"The three-tails approach as a new strategy to improve selectivity of action of sulphonamide inhibitors against tumour-associated carbonic anhydrase IX and XII","volume":"37","author":"Bonardi","year":"2022","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.cbi.2024.111284_bib43","doi-asserted-by":"crossref","first-page":"13143","DOI":"10.1021\/acs.jmedchem.2c00982","article-title":"Development of hydrogen sulfide-releasing carbonic anhydrases IX- and XII-selective inhibitors with enhanced antihyperalgesic action in a rat model of arthritis","volume":"65","author":"Bonardi","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2024.111284_bib44","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/14756366.2018.1428572","article-title":"Carbon-versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors?","volume":"33","author":"Supuran","year":"2018","journal-title":"J. Enzyme Inhib Med Chem."},{"key":"10.1016\/j.cbi.2024.111284_bib45","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.4155\/fmc.14.68","article-title":"Sulfonamides and their isosters as carbonic anhydrase inhibitors","volume":"6","author":"Carta","year":"2014","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.cbi.2024.111284_bib46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.31083\/j.jmcm.2019.02.7181","article-title":"Naphthol-derived Betti bases as potential SLC6A14 blockers","volume":"2","author":"Puerta","year":"2019","journal-title":"J Mol Clin Med"},{"key":"10.1016\/j.cbi.2024.111284_bib47","doi-asserted-by":"crossref","first-page":"D437","DOI":"10.1093\/nar\/gkaa1038","article-title":"RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences","volume":"49","author":"Burley","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cbi.2024.111284_sref48","series-title":"Schr\u00f6dinger Suite Release 2022-2","year":"2022"},{"key":"10.1016\/j.cbi.2024.111284_bib48a","unstructured":"Maestro v.13.2;."},{"key":"10.1016\/j.cbi.2024.111284_bib48b","unstructured":"Epik, v.6.0;."},{"key":"10.1016\/j.cbi.2024.111284_bib48c","unstructured":"Impact, v.9.5;."},{"key":"10.1016\/j.cbi.2024.111284_bib48d","unstructured":"Prime, v.5.5;."},{"key":"10.1016\/j.cbi.2024.111284_bib48e","unstructured":"Macromodel v.13.6."},{"key":"10.1016\/j.cbi.2024.111284_bib48f","unstructured":"Glide, v.9.5;."},{"key":"10.1016\/j.cbi.2024.111284_bib48g","unstructured":"Desmond, v.7.0."},{"key":"10.1016\/j.cbi.2024.111284_bib49","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1021\/jp003919d","article-title":"Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides","volume":"105","author":"Kaminski","year":"2001","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.cbi.2024.111284_bib50","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: improving force field accuracy on challenging regimes of chemical space","volume":"17","author":"Lu","year":"2021","journal-title":"J Chem Theory Comput."},{"key":"10.1016\/j.cbi.2024.111284_bib51","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2191165","article-title":"Selenium-analogs based on natural sources as cancer-associated carbonic anhydrase isoforms IX and XII inhibitors","volume":"38","author":"Astrain-Redin","year":"2023","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.cbi.2024.111284_bib52","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1021\/acsmedchemlett.3c00094","article-title":"Discovery of novel hydroxyimine-tethered benzenesulfonamides as potential human carbonic anhydrase IX\/XII inhibitors","volume":"14","author":"Peerzada","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.cbi.2024.111284_bib53","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724004307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724004307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T16:57:14Z","timestamp":1730825834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279724004307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":60,"alternative-id":["S0009279724004307"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2024.111284","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and investigation of selective human carbonic anhydrase IX, XII inhibitors using coumarins bearing a sulfonamide or biotin moiety","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2024.111284","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111284"}}